Patents by Inventor Veronica DIERMAYR

Veronica DIERMAYR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF
    Publication number: 20230366031
    Abstract: The present disclosure provides a multiplexed amplification reaction kit for identifying a subject suffering from a malignancy sensitive to treatment with an inhibitor of the Wnt signaling pathway, comprising a primer pair capable of amplifying a PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion. Also disclosed is a method of identifying sensitivity to an inhibitor of Wnt signaling in a subject suffering from a malignancy, comprising detecting the PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion with a primer pair.
    Type: Application
    Filed: April 6, 2023
    Publication date: November 16, 2023
    Applicant: Agency for Science, Technology and Research
    Inventors: Bong Hwa GAN, Masafumi INOUE, Veronica DIERMAYR
  • Kit for identifying malignancy, and uses thereof
    Patent number: 11649505
    Abstract: The present disclosure provides a multiplexed amplification reaction kit for identifying a subject suffering from a malignancy sensitive to treatment with an inhibitor of the Wnt signaling pathway, comprising a primer pair capable of amplifying a PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion. Also disclosed is a method of identifying sensitivity to an inhibitor of Wnt signaling in a subject suffering from a malignancy, comprising detecting the PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion with a primer pair.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: May 16, 2023
    Assignee: Agency for Science, Technology and Research
    Inventors: Bong Hwa Gan, Masafumi Inoue, Veronica Diermayr
  • PHARMACEUTICAL COMBINATION
    Publication number: 20220211715
    Abstract: The present invention relates generally to the field of oncology. In particular, the invention relates to a pharmaceutical combination comprising of formula (I) or a pharmaceutically acceptable salt or solvate thereof and an anti-PD-1 antibody or a pharmaceutically acceptable salt or solvate thereof for treating diseases and/or disorders related to the Wnt pathway.
    Type: Application
    Filed: April 15, 2020
    Publication date: July 7, 2022
    Inventors: Damian O'CONNELL, Vincenzo TENEGGI, Veronica DIERMAYR
  • KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF
    Publication number: 20200002772
    Abstract: The present disclosure provides a multiplexed amplification reaction kit for identifying a subject suffering from a malignancy sensitive to treatment with an inhibitor of the Wnt signaling pathway, comprising a primer pair capable of amplifying a PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion. Also disclosed is a method of identifying sensitivity to an inhibitor of Wnt signaling in a subject suffering from a malignancy, comprising detecting the PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion with a primer pair.
    Type: Application
    Filed: December 21, 2017
    Publication date: January 2, 2020
    Applicant: Agency for Science, Technology and Research
    Inventors: Bong Hwa GAN, Masafumi INOUE, Veronica DIERMAYR